Abstract:Background: Abundant α-synuclein (α-syn) protein accumulation is the pathological hallmark of Parkinson disease (PD) and it induces dopaminergic (DA) neuron apoptosis. This study explored the influence of long non-coding RNA (lncRNA) SNHG14 on α-syn expression and PD pathogenesis.Methods: PD model was established in mouse with a stereotaxic surgery. In the brain tissue of PD mice, the expression levels of SNHG14, miR-133b, α-syn and SP-1 protein were determined. Chromatin immunoprecipitation (ChIP) assay was performed to validate the binding between SP-1 and SNHG14 promoter. DA neuron viability was analyzed with CCk-8 assay. Interplay between SNHG14 and miR-133b was examined with RNA immunoprecipitation (RIP) and RNA pull-down assay. Regulatory relationship between miR-133b and α-syn was verified through dual luciferase reporter assay.Results: Compared with the sham group (n=7), the expression of SNHG14, αsyn and SP-1 protein was increased in PD mice model (n=7), while miR-133b was down-regulated. Binding between transcriptional factor SP-1 and SNHG14 promoter was enhanced by rotenone, and promoted SNHG14 expression. Interference of SNHG14 ameliorated the DA neuron injury induced by rotenone. Interaction between SNHG14 and miR-133b was identified in clonal mesencephalic DA cell line MN9D cells. MiR-133b negatively regulated α-syn expression by targeting its 3'-UTR of mRNA. SNHG14 regulated α-syn expression via targeting miR-133b. Interference of SNHG14 improved DA neuron activity that damaged by rotenone through miR-133b. Interference of SNHG14 mitigated neuron injury in PD mouse model.Conclusion: Interference of lncRNA SNHG14 expression mitigates dopaminergic neuron injury by down-regulating α-syn via targeting miR133b, which contributes to improving PD pathological state.Funding Statement: This study was supported by the grants from the Youth Entrepreneurship Foundation of the First Affiliated Hospital of Zhengzhou University.Declaration of Interests: The authors declare no conflict of interest.Ethics Approval Statement: All animal experiments were approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University.

LncRNA-T199678 Mitigates -Synuclein-Induced Dopaminergic Neuron Injury via miR-101-3p

LncRNA-T199678 Mitigates α-Synuclein-Induced Dopaminergic Neuron Injury via miR-101-3p

Exploration of the α-syn/T199678/miR-519-3p/KLF9 pathway in a PD-related α-syn pathology.

Exploration of the Α-Syn/t199678/mir-519–3p/klf9 Pathway in a PD-related Α-Syn Pathology

Knockdown of Long Non-Coding RNA AL049437 Mitigates MPP+ -Induced Neuronal Injury in SH-SY5Y Cells Via the Microrna-205-5p/mapk1 Axis.

Dopaminergic Neuron Injury in Parkinson Disease is Mitigated by Interfering Lncrna SNHG14 Expression to Regulate the Mir-133B/α-synuclein Pathway

lncRNA PART1 mitigates MPP+-induced neuronal injury in SH-SY5Y cells via micRNA-106b-5p/MCL1 axis

LncRNA HOTAIR promotes α-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in Parkinson's disease

Long Noncoding RNA SRY-box Transcription Factor 2 Overlapping Transcript Participates in Parkinson's Disease by Regulating the Microrna-942-5p/nuclear Apoptosis-Inducing Factor 1 Axis.

Long non-coding RNA myocardial infarction-associated transcript promotes 1-Methyl-4-phenylpyridinium ion-induced neuronal inflammation and oxidative stress in Parkinson's disease through regulating microRNA-221-3p/ transforming growth factor /nuclear factor E2-related factor 2 axis

MicroRNA-409-3p Targeting at ATXN3 Reduces the Apoptosis of Dopamine Neurons Based on the Profile of Mirnas in the Cerebrospinal Fluid of Early Parkinson's Disease

Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson's Disease

High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model

LncRNA Mir-17-92a-1 Cluster Host Gene (MIR17HG) Promotes Neuronal Damage and Microglial Activation by Targeting the Microrna-153-3p/alpha-synuclein Axis in Parkinson’s Disease

Suppression of Abnormal Α-Synuclein Expression by Activation of BDNF Transcription Ameliorates Parkinson's Disease-Like Pathology.

LncRNA XIST sponges miR-199a-3p to modulate the Sp1/LRRK2 signal pathway to accelerate Parkinson’s disease progression

Down-regulated long non-coding RNA RMST ameliorates dopaminergic neuron damage in Parkinson’s disease rats via regulation of TLR/NF-κB signaling pathway

Long non-coding RNA SNHG1 mediates neuronal damage in Parkinson’s disease model cells by regulating miR-216a-3p/Bcl-2-associated X protein

LncRNA HOTAIR Promotes Neuronal Damage Through Facilitating NLRP3 Mediated-Pyroptosis Activation in Parkinson’s Disease via Regulation of miR-326/ELAVL1 Axis

Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease

Retracted Article: LncRNA MALAT1 Aggravates MPP-induced Neuronal Injury by Regulating Mir-212 in SH-SY5Y Cells